MARKET

DRIO

DRIO

DarioHealth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.47
-0.47
-3.63%
After Hours: 13.40 +0.93 +7.46% 18:36 10/23 EDT
OPEN
13.04
PREV CLOSE
12.94
HIGH
13.16
LOW
12.35
VOLUME
31.78K
TURNOVER
--
52 WEEK HIGH
22.49
52 WEEK LOW
3.020
MARKET CAP
94.66M
P/E (TTM)
-1.2233
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
DarioHealth Announces Inclusion of its Digital Therapeutics Platform in Vitality Group's New Gateway Flex Offering
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company's digital therapeutics solutions for inclusion in Vitality's new Gateway Flex offering.
PR Newswire · 10/13 13:05
DarioHealth and HMC HealthWorks Announce Partnership Agreement
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, and HMC HealthWorks, a 40-year veteran in healthcare management with clinically-integrated models of care that reduce healthcare costs and improve population health, today announced that the companies have entered
PR Newswire · 09/21 13:30
DarioHealth and HMC HealthWorks ink partnership agreement
DarioHealth (DRIO) -5% PM, and 40-year veteran healthcare management company HMC HealthWorks entered into a sales and distribution partnership, post which the latter will incorporate the former's digital therapeutics solution into its comprehensive
Seekingalpha · 09/21 13:01
DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established Scientific Advisory Board (SAB).
PR Newswire · 09/16 13:30
DRIO: Positive Price Target Catalysts
By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Second Quarter 2020 Operational and Financial Results On August 12, 2020 DarioHealth Corp. (NASDAQ:DRIO) reported second quarter earnings and filed its companion 10-Q . The company also held an investor conference call providing
Zacks Small Cap Research · 08/24 11:30
Momenta Pharmaceuticals leads healthcare gainers; Eyenovia and Galapagos among losers
Gainers: Momenta Pharmaceuticals (MNTA) +69%. iRhythm Technologies (IRTC) +18%. DarioHealth (DRIO) +16%. Verrica Pharmaceuticals (VRCA) +16%. Avalon GloboCare (AVCO) +15%.Losers: BioMarin Pharmaceutical (BMRN) -33%. Galapagos (GLPG) -23%. Eyenovia (EYEN) -19%. Timber Pharmaceuticals (TMBR) -11%. Scworx (WORX) -10%.
Seekingalpha · 08/19 15:04
DarioHealth Highlights Poster Presentation At Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference
DarioHealth Corp. (NASDAQ:DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes
Benzinga · 08/13 12:21
DarioHealth Q2 EPS $(0.68) Beats $(1.40) Estimate, Adj. Net Loss $3.25M vs Loss $4.26M In Same Qtr. Last Year, Sales $1.79M Beat $1.55M Estimate
DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.40) by 51.43 percent. This is a 423.08 percent decrease over losses of $(0.13) per share from the
Benzinga · 08/12 11:04
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DRIO. Analyze the recent business situations of DarioHealth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DRIO stock price target is 16.90 with a high estimate of 25.00 and a low estimate of 10.00.
EPS
Institutional Holdings
Institutions: 30
Institutional Holdings: 2.11M
% Owned: 27.78%
Shares Outstanding: 7.59M
TypeInstitutionsShares
Increased
5
71.77K
New
6
21.22K
Decreased
1
195
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.07%
Healthcare Equipment & Supplies
+0.12%
Key Executives
Chairman/Independent Director
Yoav Shaked
President/General Manager
Richard Anderson
Chief Executive Officer/Director
Erez Raphael
Chief Financial Officer/Treasurer/Secretary
Zvi Ben-David
Chief Operating Officer
Dror Bacher
Senior Vice President
Olivier Jarry
Senior Vice President
Barbara Stark
Other
Omar Manejwala
Director
Dennis Matheis
Director
Adam Stern
Independent Director
Allen Kamer
Independent Director
Hila Karah
Independent Director
Dennis McGrath
Independent Director
Yadin Shemmer
Independent Director
Richard Stone
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About DRIO
DarioHealth Corp. (DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The DTx products are centered around its users and include the Dario Blood Glucose Monitoring System and the Dario Smart Diabetes Management Solution, which are provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports; the DarioEngage platform, which provides support and two-way real-time connectivity between its users and their caregivers, and Dario Intelligence, which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases. The Company’s services are available direct to consumers via online marketplaces including Amazon, Walmart, Best Buy and the Google and Apple app stores.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of DarioHealth Corp stock information, including NASDAQ:DRIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DRIO stock methods without spending real money on the virtual paper trading platform.